Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials

References

• TyrerPBaldwinDGeneralised anxiety disorderLancet200636895532156216617174708
   PubMed Web of Science ®Google Scholar
• CuijpersPSijbrandijMKooleSHuibersMBerkingMAnderssonGPsychological treatment of generalized anxiety disorder: a meta-analysisClin Psychol Rev201434213014024487344
   PubMed Web of Science ®Google Scholar
• SzkodnyLENewmanMGGoldfriedMRClinical experiences in conducting empirically supported treatments for generalized anxiety disorderBehav Ther201445172024411110
   PubMed Web of Science ®Google Scholar
• SchmittRGazalleFKLimaMSCunhaASouzaJKapczinskiFThe efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysisRev Bras Psiquiatr2005271182415867979
   PubMedGoogle Scholar
• KapczinskiFLimaMSSouzaJSSchmittRAntidepressants for generalized anxiety disorderCochrane Database Syst Rev20032CD00359212804478
   PubMedGoogle Scholar
• PollackMHZaninelliRGoddardAParoxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trialJ Clin Psychiatry200162535035711411817
   PubMed Web of Science ®Google Scholar
• LiebowitzMRSteinMBTancerMCarpenterDOakesRPittsCDA randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorderJ Clin Psychiatry2002631667411838629
   PubMed Web of Science ®Google Scholar
• RickelsKZaninelliRMcCaffertyJBellewKIyengarMSheehanDParoxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled studyAm J Psychiatry2003160474975612668365
   PubMed Web of Science ®Google Scholar
• StocchiFNorderaGJokinenRHEfficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorderJ Clin Psychiatry200364325025812716265
   PubMed Web of Science ®Google Scholar
• AllgulanderCDahlAAAustinCEfficacy of sertraline in a 12-week trial for generalized anxiety disorderAm J Psychiatry200416191642164915337655
   PubMed Web of Science ®Google Scholar
• Brawman-MintzerOKnappRGRynnMCarterRERickelsKSertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled studyJ Clin Psychiatry200667687488116848646
   PubMed Web of Science ®Google Scholar
• VariaIRauscherFTreatment of generalized anxiety disorder with citalopramInt Clin Psychopharmacol200217310310711981350
   PubMed Web of Science ®Google Scholar
• DavidsonJRBoseAKorotzerAZhengHEscitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose studyDepress Anxiety200419423424015274172
   PubMed Web of Science ®Google Scholar
• DavidsonJRBoseAWangQSafety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorderJ Clin Psychiatry200566111441144616420082
   PubMed Web of Science ®Google Scholar
• KatzIRReynoldsCF3rdAlexopoulosGSHackettDVenlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trialsJ Am Geriatr Soc2002501182512028242
   PubMed Web of Science ®Google Scholar
• WrightAVandenbergCDuloxetine in the treatment of generalized anxiety disorderInt J Gen Med2009215316220360899
   PubMedGoogle Scholar
• BystritskyAKerwinLFeusnerJDVapnikTA pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorderPsychopharmacol Bull2008411465118362870
   PubMedGoogle Scholar
• SteinMBPollackMHBystritskyAKelseyJEManganoRMEfficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trialPsychopharmacology (Berl)2005177328028815258718
   PubMed Web of Science ®Google Scholar
• KoponenHAllgulanderCEricksonJEfficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physiciansPrim Care Companion J Clin Psychiatry20079210010717607331
   PubMedGoogle Scholar
• BoseAKorotzerAGommollCLiDRandomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorderDepress Anxiety2008251085486118050245
   PubMed Web of Science ®Google Scholar
• AllgulanderCHackettDSalinasEVenlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging studyBr J Psychiatry2001179152211435263
   PubMed Web of Science ®Google Scholar
• RynnMRussellJEricksonJEfficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trialDepress Anxiety200825318218917311303
   PubMed Web of Science ®Google Scholar
• FeighnerJPOverview of antidepressants currently used to treat anxiety disordersJ Clin Psychiatry199960Suppl 22182210634351
   PubMedGoogle Scholar
• RickelsKRynnMPharmacotherapy of generalized anxiety disorderJ Clin Psychiatry200263Suppl 1491612562113
   PubMedGoogle Scholar
• MontgomerySATolerability of serotonin norepinephrine reuptake inhibitor antidepressantsCNS Spectr2008137 Suppl 11273318622372
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edArlington, VAAmerican Psychiatric Publishing2013
   Google Scholar
• MontiJMMontiDSleep disturbance in generalized anxiety disorder and its treatmentSleep Med Rev20004326327612531169
   PubMed Web of Science ®Google Scholar
• BellevilleGCousineauHLevrierKSt-Pierre-DelormeMEMarchandAThe impact of cognitive-behavior therapy for anxiety disorders on concomitant sleep disturbances: a meta-analysisJ Anxiety Disord201024437938620369395
   PubMed Web of Science ®Google Scholar
• TsypesAAldaoAMenninDSEmotion dysregulation and sleep difficulties in generalized anxiety disorderJ Anxiety Disord201327219720323474909
   PubMed Web of Science ®Google Scholar
• RoerigJLDiagnosis and management of generalized anxiety disorderJ Am Pharm Assoc (Wash)199939681182110609447
   PubMedGoogle Scholar
• Canadian Agency for Drugs and Technologies in HealthShort- and Long-Term Use of Benzodiazepines in Patients with Generalized Anxiety Disorder: A Review of GuidelinesOttawa (ON)Canadian Agency for Drugs and Technologies in Health2014
   Google Scholar
• WilsonSArgyropoulosSAntidepressants and sleep: a qualitative review of the literatureDrugs200565792794715892588
   PubMed Web of Science ®Google Scholar
• DeVaneCLNemeroffCBClinical pharmacokinetics of quetiapine: an atypical antipsychoticClin Pharmacokinet200140750952211510628
   PubMed Web of Science ®Google Scholar
• FigueroaCBrecherMHamer-MaanssonJEWinterHPharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate releaseProg Neuropsychopharmacol Biol Psychiatry200933219920418948162
   PubMed Web of Science ®Google Scholar
• BandelowBChouinardGBobesJExtended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled studyInt J Neuropsychopharmacol201013330532019691907
   PubMed Web of Science ®Google Scholar
• KhanAJoyceMAtkinsonSEggensIBaldytchevaIErikssonHA randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorderJ Clin Psychopharmacol201131441842821694613
   PubMed Web of Science ®Google Scholar
• KatzmanMABrawman-MintzerOReyesEBOlaussonBLiuSErikssonHExtended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trialInt Clin Psychop-harmacol20112611124
   PubMed Web of Science ®Google Scholar
• HoracekJBubenikova-ValesovaVKopecekMMechanism of action of atypical antipsychotic drugs and the neurobiology of schizophreniaCNS Drugs200620538940916696579
   PubMed Web of Science ®Google Scholar
• JensenNHRodriguizRMCaronMGWetselWCRothmanRBRothBLN-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine’s antidepressant activityNeuropsychopharmacology200833102303231218059438
   PubMed Web of Science ®Google Scholar
• BakkenGVRudbergIMoldenERefsumHHermannMPharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patientsTher Drug Monit201133222222621383647
   PubMed Web of Science ®Google Scholar
• GoldsteinJMNybergSBrecherMPreclinical mechanisms for the broad spectrum of antipsychotic, antidepressant and mood stabilizing properties of SeroquelEuropean Psychiatry200823Suppl 2S202
   Google Scholar
• ManeetonNManeetonBSrisurapanontMMartinSDQuetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trialsBMC Psychiatry20121216023017200
   PubMed Web of Science ®Google Scholar
• MeridethCCutlerAJSheFErikssonHEfficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled studyInt Clin Psychopharmacol2012271405422045039
   PubMed Web of Science ®Google Scholar
• SrisurapanontMManeetonBManeetonNQuetiapine for schizophreniaCochrane Database Syst Rev20042CD00096715106155
   PubMedGoogle Scholar
• ManeetonBManeetonNSrisurapanontMChittawatanaratKQuetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trialDrug Des Devel Ther20137657667
   PubMed Web of Science ®Google Scholar
• SuttajitSSrisurapanontMManeetonNManeetonBQuetiapine for acute bipolar depression: a systematic review and meta-analysisDrug Des Devel Ther20148827838
   PubMed Web of Science ®Google Scholar
• HamiltonMThe assessment of anxiety states by ratingBr J Med Psychol1959321505513638508
   PubMed Web of Science ®Google Scholar
• HigginsJPTAltmanDGAssessing risk of bias in included studiesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]The Cochrane Collaboration2009
   Google Scholar
• CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisLancet2009373966574675819185342
   PubMed Web of Science ®Google Scholar
• PapakostasGITolerability of modern antidepressantsJ Clin Psychiatry200869Suppl E181318494538
   PubMed Web of Science ®Google Scholar
• DeeksJJHigginsJPTAltmanDGAnalysing data and undertaking meta-analysesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]The Cochrane Collaboration2009
   Google Scholar
• WiebeNVandermeerBPlattRWKlassenTPMoherDBarrowmanNJA systematic review identifies a lack of standardization in methods for handling missing variance dataJ Clin Epidemiol200659434235316549255
   PubMed Web of Science ®Google Scholar
• SterneJACEggerMMoherDAddressing Reporting BiasesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]The Cochrane Collaboration2009
   Google Scholar
• EndicottJSvedsaterHLocklearJCEffects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorderNeuropsychiatr Dis Treat2012830131122848184
   PubMed Web of Science ®Google Scholar
• MontgomerySALocklearJCSvedsaterHErikssonHEfficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorderInt Clin Psychopharmacol201429525226224394383
   PubMed Web of Science ®Google Scholar
• SheehanDVSvedsaterHLocklearJCErikssonHEffects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance studyJ Affect Disord2013151390691324135509
   PubMed Web of Science ®Google Scholar
• AstraZenecaSafety & Efficacy Study of Quetiapine Fumarate (SEROQUEL^®) vs Placebo in Generalized Anxiety Disorder (TITANIUM) Available fom: https://clinicaltrials.gov/ct2/show/NCT00329264. NLM identifier: NCT00329264Accessed October 18, 2015
   Google Scholar
• AstraZenecaEfficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder (SILVER) Available from: https://clinicaltrials.gov/ct2/show/NCT00322595. NLM identifier: NCT00322595Accessed October 18, 2015
   Google Scholar
• AstraZenecaSafety & Efficacy Study of Quetiapine Fumarate (SEROQUEL^®) vs Placebo & Active Control in Generalized Anxiety Disorder (GOLD) Available from: https://clinicaltrials.gov/ct2/show/NCT00329446. NLM identifier: NCT00329446Accessed October 18, 2015
   Google Scholar
• MeridethCCutlerANeijberASheFErikssonHExtended release quetiapine fumarate monotherapy for generalized anxiety disorder (gad): a randomized, placebo and escitalopram-controlled studyWorld Psychiatry20098Suppl 1215 meeting: April 1–4, 2009; Florence, Italy
   Google Scholar
• Brawman-MintzerONietertPJRynnMRickelsKQuetiapine monotherapy in patients with generalized anxiety disorderPaper presented at: 46th Annual NCDEU (New Clinical Drug Evaluation Unit) meetingJune 12–15, 2006Boca Raton, FL
   Google Scholar
• SheehanDVSvedsaterHLocklearJErikssonHEffects of extended release quetiapine fumarate on long-term functioning and sleep quality in patients with generalized anxiety disorder (GAD) [conference abstract]Paper presented at: 163rd Annual Meeting of the American Psychiatric AssociationMay 22–26, 2010New Orleans, LA
   Google Scholar
• WuWYWangGBallSGDesaiahDAngQQDuloxetine versus placebo in the treatment of patients with generalized anxiety disorder in ChinaChin Med J (Engl)2011124203260326822088518
   PubMed Web of Science ®Google Scholar
• GoodmanWKBoseAWangQTreatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trialsJ Affect Disord2005872–316116715982747
   PubMed Web of Science ®Google Scholar
• PapadimitriouGNLinkowskiPSleep disturbance in anxiety disordersInt Rev Psychiatry200517422923616194794
   PubMed Web of Science ®Google Scholar
• SteinDJLopezAGEffects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorderAdv Ther201128111021103722057726
   PubMed Web of Science ®Google Scholar
• DolderCRNelsonMHIlerCAThe effects of mirtazapine on sleep in patients with major depressive disorderAnn Clin Psychiatry201224321522422860241
   PubMedGoogle Scholar
• LenzeEJRollmanBLShearMKEscitalopram for older adults with generalized anxiety disorder: a randomized controlled trialJAMA2009301329530319155456
   PubMed Web of Science ®Google Scholar